ABUS - Arbutus to Participate in Two Upcoming Investor Conferences | Benzinga
WARMINSTER, Pa., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (NASDAQ:ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced that the Arbutus management team will participate in and host one-on-one meetings at the following two upcoming investor conferences:
H.C. Wainwright 25th Annual Global Investment Conference: Formal Presentation on September 12, 2023 at 3:30 pm ET
Baird's 2023 Global Healthcare Conference: Fireside Chat on September 13, 2023 at 7:55 am ET
To access the live webcast of the ...